Showing 3 posts of 3 posts found.

Sativex image

Late-stage failure for Otsuka and GW cancer pain drug

January 9, 2015
Sales and Marketing Cancer, Epidiolex, GW, MS, NICE, Otsuka, Sativex, cannabidiol, nabiximols

Otsuka and GW Pharmaceutical’s multiple sclerosis drug Sativex has failed to meet the primary endpoint in its first Phase III …

Pharmaceutical manufacturing: news in brief

July 22, 2009
Manufacturing and Production GW

Pharmafocus presents a round-up of developments in manufacturing, including facility updates from GW and Viva Biopharm, GMP problems at an …

Cannabis-derived MS drug filed for European approval

May 20, 2009
Research and Development, Sales and Marketing GW, Sativex

Sativex, the cannabis-derived product developed by GW Pharmaceuticals, could be finally set for European approval after five years of delay. …

Latest content